{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:59:27Z","timestamp":1773802767693,"version":"3.50.1"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,3,13]]},"DOI":"10.18632\/oncotarget.23756","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T12:09:32Z","timestamp":1514549372000},"page":"14849-14861","source":"Crossref","is-referenced-by-count":14,"title":["Effects of carbon ion beam alone or in combination with cisplatin on malignant mesothelioma cells <i>in vitro<\/i>"],"prefix":"10.18632","volume":"9","author":[{"given":"Sei","family":"Sai","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Applied Radiation Bioscience, Korea Institute of Radiological and Medical Sciences, Gongneung-dong, Nowon-Gu, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Breast Center, Dokkyo Medical University Hospital, Mibu-machi, Shimotsuga-gun, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Vares","sequence":"additional","affiliation":[{"name":"Okinawa Institute of Science and Technology (OIST), Advanced Medical Instrumentation Unit, Onna-son, Okinawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyoshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Chiba Foundation for Health Promotion and Disease Prevention, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Yang","year":"2012","journal-title":"J Cell Physiol"},{"key":"2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.07.012","article-title":"New therapeutic strategies for malignant pleural mesothelioma","volume":"123","author":"Alfieri","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2307\/3579446","article-title":"Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy","volume":"147","author":"Ohara","year":"1997","journal-title":"Radiat Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1269\/jrr.48.A15","article-title":"Irradiation System for HIMAC","volume":"48","author":"Kanai","year":"2007","journal-title":"J Radiat Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ijc.26445","article-title":"Repair of DNA damage induced by accelerated heavy ions\u2014a mini review","volume":"130","author":"Okayasu","year":"2012","journal-title":"Int J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fonc.2016.00023","article-title":"Effects of Charged Particles on Human Tumor Cells","volume":"6","author":"Takahashi","year":"2016","journal-title":"Front Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jjco\/hys104","article-title":"A review of update clinical results of carbon ion radiotherapy","volume":"42","author":"Kamada","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S1470-2045(14)70412-7","article-title":"Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience","volume":"16","author":"Chu","year":"2015","journal-title":"Lancet Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1471-2407-14-304","article-title":"Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity","volume":"14","author":"Karoubi","year":"2014","journal-title":"BMC Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2012.02.054","article-title":"Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells","volume":"419","author":"Morimoto","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"11","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1158\/0008-5472.CAN-07-0895","article-title":"Cancer stem cells in radiation resistance","volume":"67","author":"Rich","year":"2007","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1634\/stemcells.2006-0136","article-title":"Successful therapy must eradicate cancer stem cells","volume":"24","author":"Michor","year":"2006","journal-title":"Stem Cells"},{"key":"13","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","article-title":"The developing cancer stem-cell model: clinical challenges and opportunities","volume":"13","author":"Medema","year":"2012","journal-title":"Lancet Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/S1470-2045(12)70196-1","article-title":"Overcoming resistance of cancer stem cells","volume":"13","author":"Durante","year":"2012","journal-title":"Lancet Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1158\/0008-5472.CAN-10-2926","article-title":"Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays","volume":"71","author":"Okayasu","year":"2011","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.radonc.2012.08.009","article-title":"Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells","volume":"105","author":"Kamada","year":"2012","journal-title":"Radiother Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-015-0429-7","article-title":"Carbon Ion Beam Combined with Cisplatin Effectively Disrupts Triple Negative Breast Cancer Stem-Like Cells","volume":"14","author":"Hayashi","year":"2015","journal-title":"Mol Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.18632\/oncotarget.3584","article-title":"Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cellsand","volume":"6","author":"Shirai","year":"2015","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1200\/JCO.1993.11.8.1559","article-title":"Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.","volume":"11","author":"Leone","year":"1993","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"11641","DOI":"10.18632\/oncotarget.2604","article-title":"Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma","volume":"5","author":"Blanquart","year":"2014","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0360-3016(00)00606-4","article-title":"Change in radiosensitivity with fractionated-dose irradiation of carbon-ion beams in five different human cell lines","volume":"48","author":"Ando","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fct.2016.08.033","article-title":"Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells","volume":"97","author":"Lee","year":"2016","journal-title":"Food Chem Toxicol"},{"key":"23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2010.12.054","article-title":"Identification of cancer stem cell markers in human malignant mesothelioma cells","volume":"404","author":"Morimoto","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2015.09.009","article-title":"Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling","volume":"35","author":"Skvortsov","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2012.03.024","article-title":"Targeting a cornerstone of radiation resistance: cancer stem cell","volume":"322","author":"Magn\u00e9","year":"2012","journal-title":"Cancer Lett"},{"key":"26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/stem.1222","article-title":"Multiple facets of the DNA damage response contribute to the radioresistance of mouse mesenchymal stromal cell lines","volume":"31","author":"Ceredig","year":"2013","journal-title":"Stem Cells"},{"key":"27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3892\/ol.2014.2049","article-title":"Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis","volume":"7","author":"Liu","year":"2014","journal-title":"Oncol Lett"},{"key":"28","doi-asserted-by":"publisher","first-page":"15551","DOI":"10.18632\/oncotarget.390","article-title":"Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance","volume":"6","author":"S\u00e1nchez-Prieto","year":"2015","journal-title":"Oncotarget"},{"key":"29","first-page":"134","article-title":"Cisplatin induces differentiation of breast cancer cells","volume":"3","author":"Filgueira","year":"2013","journal-title":"Front Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"e70107","DOI":"10.1371\/journal.pone.0070107","article-title":"Visualisation of \u03b3H2AX foci caused by heavy ion particle traversal; distinction between core track versus non-track damage","volume":"8","author":"Shibata","year":"2013","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"crossref","first-page":"24263","DOI":"10.1074\/jbc.M112.344911","article-title":"Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways","volume":"287","author":"Turchi","year":"2012","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mrfmmm.2009.07.002","article-title":"Cisplatin sensitivity is related to late DNA damage processing and checkpoint control rather than to the early DNA damage response","volume":"670","author":"Fritz","year":"2009","journal-title":"Mutat Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1476-4598-13-227","article-title":"Agonist activation of estrogen receptor beta (ER\u03b2) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity","volume":"13","author":"Moro","year":"2014","journal-title":"Mol Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/carcin\/23.6.1017","article-title":"Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma","volume":"23","author":"Bueno","year":"2002","journal-title":"Carcinogenesis"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:56:52Z","timestamp":1589036212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":34,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,3,13]]}},"alternative-id":["23756","29599911"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23756","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}